nach oben

Annals of Hematology

Erschienen in:

07.09.2017 | Letter to the Editor

Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations

verfasst von: Prabhakar Kedar, Vaishali Parmar, Rati Devendra, Vinod Gupta, Prashant Warang, Manisha Madkaikar

Erschienen in: Annals of Hematology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Iolascon I, D’Agostaro G, Perrotta S et al (1996) Congenital dyserythropoietic anemia type II: molecular basis and clinical aspect. Haematologica 81:543–559PubMed

Heimpel H, Forteza-Vila J, Queisser W et al (1971) Electron and light microscopic study of the erythropoiesis of patients with congenital dyserythropoietic anemia. Blood 37:299–310PubMed

Babbs C, Roberts NA, Sanchez-Pulido L, McGowan SJ, Ahmed MR, Brown JM et al (2013) Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I. Haematologica 98:1383–1387CrossRefPubMedPubMedCentral

Bianchi P, Fermo E, Vercellati C, Boschetti C, Barcellini W, Iurlo A et al (2009) Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum Mutat 30:1292–1298CrossRefPubMed

Russo R, Esposito MR, Asci R et al (2010) Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel mutations in SEC23B gene. Am J Hematol 85:915–920CrossRefPubMedPubMedCentral

Iolascon A, Russo R, Esposito MR, Asci R, Piscopo C, Perrotta S et al (2010) Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship. Haematologica 95:708–715CrossRefPubMed

Heimpel H, Kellermann K, Neuschwander N, Högel J, Schwarz K (2010) The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells. Haematologica 95:1034–1036CrossRefPubMedPubMedCentral

Heimpel H, Matuschek A, Ahmed M et al (2010) Frequency of congenital dyserythropoietic anemias in Europe. Eur J Haematol 85:20–25PubMed

Kedar PS, Colah RB, Kulkarni SS, Ghosh K, Mohanty D (2003) Experience with eosin-5′-maleimide as a diagnostic tool for red cell membrane disorders. Clinical Laboratory Hematology 25:373–376CrossRef

10.

Warang P, Gupta M, Kedar PS, Ghosh K, Colah RB (2011) Flow cytometric osmotic fragility—an effective screening approach for red cell membranopathies. Cytometry: Part B - Clinical Cytometry 80:186–190CrossRef

11.

Bianchi P, Fermo E, Vercellati C, Marcello AP, Porretti L, Cortelezzi A, Barcellini W, Zanella A (2012) Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica 97:516–523CrossRefPubMedPubMedCentral

12.

Roy NB, Wilson EA, Henderson S et al (2016) A novel 33-gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias. Br J Haematol 175:318–330CrossRefPubMedPubMedCentral

13.

Singleton B, Bansal D, Varma N, Das R, Naseem S, Saikia UN, Malhotra P, Varma S, Marwaha RK, King M-J, Ahmed M (2015) Homozygosity mapping reveals founder SEC23B-Y462C mutations in Indian congenital dyserythropoietic anemia type II. Clin Genet 88:195–197CrossRefPubMed

14.

Schwarz K, Iolascon A, Verissimo F, Trede NS, Horsley W, Chen W et al (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41:936–940CrossRefPubMed

15.

Mancias JD, Goldberg J (2007) The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope. Mol Cell 26:403–414CrossRefPubMed

16.

Iolascon A, Heimpel H, Wahlin A, Tamary H (2013) Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. Blood 122:2162–2166CrossRefPubMedPubMedCentral

17.

Singleton BK, Ahmed M, Green CA, Heimpel H, Wozniak MJ, Ranjha L, Seeney F, Bomford A, Mehta P, Gues TA, Mushens R, King M-J (2016) CD44 as a potential screening marker for preliminary differentiation between congenital dyserythropoietic anemia type II and hereditary spherocytosis. Cytometry Part B DOI. https://doi.org/10.1002/cyto.b.21488

Titel: Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations
verfasst von: Prabhakar Kedar
Vaishali Parmar
Rati Devendra
Vinod Gupta
Prashant Warang
Manisha Madkaikar
Publikationsdatum: 07.09.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 12/2017
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-017-3116-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Congenital dyserythropoietic anemia type II mimicking hereditary spherocytosis in Indian patient with SEC23B-Y462C mutations

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2017

Clinical features of hematological disorders with increased large granular lymphocytes (LGLs): a retrospective study

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant

Interleukin-6 in idiopathic multicentric Castleman’s disease after long-term tocilizumab

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin